$APYP
APPYEA, INC

2015 Q2 Form 10-Q Financial Statement

#000155724015000340 Filed on May 20, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q1
Revenue $0.00 $871.00 $2.301K
YoY Change -62.15% 1476.03%
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00 $871.00
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $600.0K $1.798K $4.831K
YoY Change 5900.0% -62.78% 58.39%
% of Gross Profit 206.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $60.00K $15.62K $10.62K
YoY Change 50.0% 47.1%
% of Gross Profit 1792.77%
Operating Expenses $610.0K $182.0K $46.33K
YoY Change 2950.0% 292.97% 457.73%
Operating Profit -$610.0K -$181.2K -$44.02K
YoY Change 311.53%
Interest Expense -$100.0K $15.00K $687.00
YoY Change 2083.55%
% of Operating Profit
Other Income/Expense, Net $0.00 -$21.39K
YoY Change
Pretax Income -$710.0K -$200.0K -$40.00K
YoY Change 3450.0% 400.0%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$710.0K -$202.6K -$44.71K
YoY Change 3450.0% 353.05% 399.06%
Net Earnings / Revenue -23256.6% -1943.11%
Basic Earnings Per Share
Diluted Earnings Per Share -$4.43 -$1.17 -$0.23
COMMON SHARES
Basic Shares Outstanding 36.27M shares 34.49M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents $265.00 $8.194K $2.439K
Short-Term Investments
Other Short-Term Assets $1.500M
YoY Change
Inventory
Prepaid Expenses $1.498M $1.611M $654.00
Receivables $339.00 $1.024K
Other Receivables $0.00
Total Short-Term Assets $1.499M $1.620M $4.117K
YoY Change 33854.41% 39237.07%
LONG-TERM ASSETS
Property, Plant & Equipment $76.57K $92.19K $82.98K
YoY Change 5.82% 11.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $76.57K $92.19K $82.98K
YoY Change 5.82% 11.1%
TOTAL ASSETS
Total Short-Term Assets $1.499M $1.620M $4.117K
Total Long-Term Assets $76.57K $92.19K $82.98K
Total Assets $1.576M $1.712M $87.10K
YoY Change 1952.2% 1865.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.277K $11.09K $4.981K
YoY Change 913.51% 122.73%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $70.00K
YoY Change 133.33%
Total Short-Term Liabilities $236.7K $191.9K $35.32K
YoY Change 677.07% 443.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $236.7K $191.9K $35.32K
Total Long-Term Liabilities $0.00
Total Liabilities $236.7K $191.9K
YoY Change 677.07%
SHAREHOLDERS EQUITY
Retained Earnings -$1.140M -$427.4K
YoY Change 851.36%
Common Stock $3.784K $3.626K $3.449K
YoY Change 9.65% 5.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.339M $1.520M $51.78K
YoY Change
Total Liabilities & Shareholders Equity $1.576M $1.712M $87.10K
YoY Change 1952.2% 1865.32%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$710.0K -$202.6K -$44.71K
YoY Change 3450.0% 353.05% 399.06%
Depreciation, Depletion And Amortization $60.00K $15.62K $10.62K
YoY Change 50.0% 47.1%
Cash From Operating Activities -$80.00K
YoY Change 33.33%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.00K
YoY Change 100.0%
NET CHANGE
Cash From Operating Activities -80.00K
Cash From Investing Activities 0.000
Cash From Financing Activities 80.00K
Net Change In Cash 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$80.00K
Capital Expenditures $0.00
Free Cash Flow -$80.00K
YoY Change 14.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Registrant Name
EntityRegistrantName
APPYEA, INC
dei Entity Central Index Key
EntityCentralIndexKey
0001568969
dei Trading Symbol
TradingSymbol
apyp
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36266989 shares
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4404 usd
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8194 usd
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31150 usd
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2439 usd
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11 usd
CY2014Q2 us-gaap Assets Current
AssetsCurrent
4415 usd
CY2015Q1 us-gaap Assets Current
AssetsCurrent
1619507 usd
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
72364 usd
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92187 usd
CY2014Q2 us-gaap Assets
Assets
76779 usd
CY2015Q1 us-gaap Assets
Assets
1711693 usd
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
422 usd
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
11094 usd
CY2015Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
154095 usd
CY2014Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
30037 usd
CY2015Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
26712 usd
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
30459 usd
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
191901 usd
CY2014Q2 us-gaap Liabilities
Liabilities
30459 usd
CY2015Q1 us-gaap Liabilities
Liabilities
191901 usd
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
3451 usd
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
3626 usd
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
162221 usd
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1943091 usd
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-119852 usd
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-427425 usd
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
46320 usd
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
1519792 usd
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76779 usd
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1711693 usd
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
55811 usd
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
95988 usd
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34512660 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36266989 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34512660 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36266989 shares
CY2014Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
2301 usd
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
6968 usd
CY2015Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
871 usd
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
2950 usd
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
84 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2721 usd
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
149 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17436 usd
CY2014Q1 us-gaap Professional Fees
ProfessionalFees
30879 usd
us-gaap Professional Fees
ProfessionalFees
43332 usd
CY2015Q1 us-gaap Professional Fees
ProfessionalFees
164632 usd
us-gaap Professional Fees
ProfessionalFees
185785 usd
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4747 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7451 usd
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1649 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21354 usd
CY2014Q1 us-gaap Depreciation
Depreciation
10615 usd
us-gaap Depreciation
Depreciation
31438 usd
CY2015Q1 us-gaap Depreciation
Depreciation
15615 usd
us-gaap Depreciation
Depreciation
40177 usd
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
46325 usd
us-gaap Operating Expenses
OperatingExpenses
84942 usd
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
182045 usd
us-gaap Operating Expenses
OperatingExpenses
264752 usd
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-44024 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-77974 usd
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-181174 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-261802 usd
CY2015Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
4979 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
6929 usd
CY2014Q1 us-gaap Interest Expense
InterestExpense
687 usd
us-gaap Interest Expense
InterestExpense
2400 usd
CY2015Q1 us-gaap Interest Expense
InterestExpense
26370 usd
us-gaap Interest Expense
InterestExpense
52699 usd
CY2014Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-687 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2400 usd
CY2015Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-21391 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-45770 usd
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-44711 usd
us-gaap Net Income Loss
NetIncomeLoss
-80374 usd
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-202565 usd
us-gaap Net Income Loss
NetIncomeLoss
-307573 usd
us-gaap Net Income Loss
NetIncomeLoss
427425 usd
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34491660 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34491660 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34541979 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36266989 shares
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
22516 usd
apyp Interest On Origination
InterestOnOrigination
24559 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-6929 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1307 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-455 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5430 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10672 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2403 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5624 usd
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
6000 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23250 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
4261 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
10000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
47000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2000 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3739 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
68250 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
60000 usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-26450 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-64460 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-28711 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3790 usd
us-gaap Nature Of Operations
NatureOfOperations
<div style="font: bold 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">1. NATURE OF OPERATIONS</div> <div style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">AppYea, Inc. ("AppYea", "the Company", "we" or "us") was incorporated in the State of South Dakota on November 26, 2012 to engage in the acquisition, purchase, maintenance and creation of mobile software applications. The Company is in the development stage with no significant revenues and a limited operating history.</div> <div style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company's common stock is traded on the OTC Markets (</font><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">www.otcmarkets.com</font><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">) under the symbol "APYP".&#160; The first day of trading on the OTC Markets was December 15, 2014.</font></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font: italic 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">Use of Estimates and Assumptions</div> <div style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">The preparation of financial statements in conformity with generally accepted accounting principles requires that management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</div>
us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<div style="font: italic 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">Derivative Financial Instruments</div> <div style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. We evaluate all of our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company used a Black Scholes valuation model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</div>
CY2014Q1 us-gaap Advertising Expense
AdvertisingExpense
84 usd
us-gaap Advertising Expense
AdvertisingExpense
2721 usd
CY2015Q1 us-gaap Advertising Expense
AdvertisingExpense
149 usd
us-gaap Advertising Expense
AdvertisingExpense
17436 usd
CY2015Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
113949 usd
CY2015Q1 us-gaap Interest Payable Current
InterestPayableCurrent
9661 usd
CY2015Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
100 shares
us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
voting rights of 1,000 share of common stock
CY2014Q1 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
44711 usd
us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
80374 usd
CY2015Q1 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
202565 usd
us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
307573 usd
CY2014Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-44711 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-80374 usd
CY2015Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-202565 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-307573 usd
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
40750 usd
CY2015Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
145325 usd
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
40750 usd
CY2015Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
145325 usd
CY2014Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2015Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2015Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
427425 usd
CY2015Q1 us-gaap Convertible Debt
ConvertibleDebt
132000 usd
CY2015Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1611313 usd
apyp Deferred Financing Costs
DeferredFinancingCosts
24661 usd
apyp Consulting Fees Paid In Stock
ConsultingFeesPaidInStock
146483 usd

Files In Submission

Name View Source Status
0001557240-15-000340-index-headers.html Edgar Link pending
0001557240-15-000340-index.html Edgar Link pending
0001557240-15-000340.txt Edgar Link pending
0001557240-15-000340-xbrl.zip Edgar Link pending
apyp-20150331.xsd Edgar Link pending
apyp-2015mar31_10q3.htm Edgar Link pending
ex-31.htm Edgar Link pending
ex-32.htm Edgar Link pending
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
apyp-20150331_cal.xml Edgar Link unprocessable
apyp-20150331_def.xml Edgar Link unprocessable
apyp-20150331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
apyp-20150331_pre.xml Edgar Link unprocessable
apyp-20150331.xml Edgar Link completed